← Insider Monitor

SKYE
Skye Bioscience, Inc.
Recent activity from public SEC and congressional filings.
18
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Schwab Andrew J.Insider | Sell | $96K | 253,080at $0.38 | Aug 18, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $96K | 253,080at $0.38 | Aug 18, 2026 |
| Schwab Andrew J.Insider | Sell | $20K | 57,476at $0.35 | Aug 19, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $20K | 57,476at $0.35 | Aug 19, 2026 |
| Schwab Andrew J.Insider | Sell | $17K | 45,090at $0.38 | Aug 18, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $17K | 45,090at $0.38 | Aug 18, 2026 |
| Schwab Andrew J.Insider | Sell | $4K | 10,255at $0.35 | Aug 19, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $4K | 10,255at $0.35 | Aug 19, 2026 |
| Schwab Andrew J.Insider | Sell | $2K | 6,495at $0.32 | Aug 20, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $2K | 6,495at $0.32 | Aug 20, 2026 |
| Schwab Andrew J.Insider | Sell | $695 | 1,830at $0.38 | Aug 18, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $695 | 1,830at $0.38 | Aug 18, 2026 |
| Schwab Andrew J.Insider | Sell | $371 | 1,159at $0.32 | Aug 20, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $371 | 1,159at $0.32 | Aug 20, 2026 |
| Schwab Andrew J.Insider | Sell | $143 | 409at $0.35 | Aug 19, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $143 | 409at $0.35 | Aug 19, 2026 |
| Schwab Andrew J.Insider | Sell | $15 | 46at $0.32 | Aug 20, 2026 |
| 5AM Partners VII, LLCInsider | Sell | $15 | 46at $0.32 | Aug 20, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for SKYE.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable SKYE activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.